The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Cancer

• Publication date

  2015-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.29147PMID 25138562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer

  2014influential reference
• Prostate Stromal Cells Express the Progesterone Receptor to Control Cancer Cell Mobility

  2014cited by this paper
• Mechanisms of the androgen receptor splicing in prostate cancer cells

  2014cited by this paper
• High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.

  2014cited by this paper
• Glucocorticoids and prostate cancer treatment: friend or foe?

  2014cited by this paper
• FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells.

  2013cited by this paper
• Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.

  2013influential reference
• The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.

  2013cited by this paper
• Expression and function of the progesterone receptor in human prostate stroma provide novel insights to cell proliferation control.

  2013cited by this paper
• Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.

  2013cited by this paper
• Increased survival with enzalutamide in prostate cancer after chemotherapy.

  2012cited by this paper
• The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

  2012cited by this paper
• Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions

  2012cited by this paper
• Cooperation between Polycomb and androgen receptor during oncogenic transformation.

  2012cited by this paper
• Expression and function of myometrial PSF suggest a role in progesterone withdrawal and the initiation of labor.

  2012cited by this paper
• From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer

  2012cited by this paper
• The androgen/androgen receptor axis in prostate cancer

  2012cited by this paper
• Androgen receptor rediscovered: the new biology and targeting the androgen receptor therapeutically.

  2011cited by this paper
• Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.

  2011cited by this paper
• Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1.

  2011cited by this paper
• Molecular characterization of neuroendocrine prostate cancer (NEPC) and identification of new drug targets.

  2011cited by this paper
• Receptor-DNA interactions: EMSA and footprinting.

  2009cited by this paper
• In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors

  2009cited by this paper
• Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

  2009cited by this paper
• Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

  2009influential reference
• Tumor suppressor activity of glucocorticoid receptor in the prostate

  2007cited by this paper
• A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth.

  2007cited by this paper
• Glucocorticoid up-regulates transforming growth factor-beta (TGF-beta) type II receptor and enhances TGF-beta signaling in human prostate cancer PC-3 cells.

  2006cited by this paper
• Glucocorticoids Suppress Tumor Angiogenesis and In vivo Growth of Prostate Cancer Cells

  2006cited by this paper
• Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression.

  2006cited by this paper
• Glucocorticoid Up-Regulates Transforming Growth Factor-β (TGF-β) Type II Receptor and Enhances TGF-β Signaling in Human Prostate Cancer PC-3 Cells

  2006cited by this paper
• Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer.

  2001cited by this paper
• Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.

  1999cited by this paper
• Intermittent androgen suppression for prostate cancer: rationale and clinical experience

  1998cited by this paper
• Intermittent Androgen Suppression for Prostate Cancer: Rationale and Clinical Experience

  1998cited by this paper
• Prostate specific antigen levels and clinical response to low dose dexamethasone for hormone‐refractory metastatic prostate carcinoma

  1995cited by this paper
• Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene.

  1993cited by this paper
• Structure and function of the glucocorticoid receptor.

  1993cited by this paper
• Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response.

  1989cited by this paper
• [The structure and function of the glucocorticoid receptor].

  1989cited by this paper
• Mechanism of glucocorticoid-induced suppression of testicular androgen biosynthesis in vitro.

  1982cited by this paper

• High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer

  2025cites this paper
• AR to GR switch modulates differential TDO2-Kyn-AhR signalling to promote the survival and recurrence of treatment-induced dormant cells in prostate cancer

  2025cites this paper
• The GR-LEDGF/p75-HSP27 Axis Contributes to Cross-Resistance Between Enzalutamide and Docetaxel in Prostate Cancer

  2025cites this paper
• Regulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer

  2024cites this paper
• Glucocorticoid receptor action in prostate cancer: the role of transcription factor crosstalk

  2024cites this paper
• ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer

  2024cites this paper
• Maternal social environment shapes yolk testosterone allocation and embryonic neural gene expression in tree swallows.

  2024cites this paper
• A TBX2-driven signaling switch from androgen receptor to glucocorticoid receptor confers therapeutic resistance in prostate cancer

  2024cites this paper
• TBX2 driven switch from Androgen Receptor to Glucocorticoid Receptor signaling confers therapeutic resistance in Prostate Cancer

  2023cites this paper
• Computationally guided discovery of novel non-steroidal AR-GR dual antagonists demonstrating potency against antiandrogen resistance

  2023cites this paper
• Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance

  2023cites this paper
• Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts

  2023cites this paper
• Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments

  2023cites this paper
• ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer

  2023cites this paper
• Androgen Action on Myogenesis Throughout the Lifespan; Comparison with Neurogenesis.

  2023cites this paper
• HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers

  2023cites this paper
• Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer

  2023cites this paper
• A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer

  2023cites this paper
• Targeting PI3K/Akt signaling in prostate cancer therapy

  2022cites this paper
• Discovery of Novel Lin28 Inhibitors to Suppress Cancer Cell Stemness

  2022cites this paper
• Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells

  2022cites this paper
• Is the glucocorticoid receptor a key player in prostate cancer?: A literature review

  2022influential citation
• Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancer

  2022cites this paper
• Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer

  2021cites this paper
• Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics

  2021cites this paper
• Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanisms

  2021cites this paper
• Glucocorticoid signaling delays castration-induced regression in murine models of prostate cancer

  2021cites this paper
• Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer

  2021cites this paper
• Steroid switch after progression on abiraterone plus prednisone in patients with metastatic castration-resistant prostate cancer: A systematic review.

  2021cites this paper
• Genome-wide crosstalk between steroid receptors in breast and prostate cancers

  2021cites this paper
• Androgen receptor signalling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration sensitive prostate cancer.

  2021cites this paper
• A PRC2-independent function for EZH2 in regulating rRNA 2′-O methylation and IRES-dependent translation

  2021cites this paper
• Tumor suppressor REIC/Dkk-3 and its interacting protein SGTA inhibit glucocorticoid receptor to nuclear transport.

  2020cites this paper
• Glucocorticoid Sexual Dimorphism in Metabolism: Dissecting the Role of Sex Hormones.

  2020cites this paper
• Cellular rewiring in lethal prostate cancer: the architect of drug resistance

  2020cites this paper
• The Role of Steroid Hormone Receptors in Urothelial Tumorigenesis

  2020cites this paper
• LncRNA GAS5 participates in the regulation of dexamethasone on androgen receptor -negative and -positive prostate cancer cell proliferation.

  2020cites this paper
• Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling

  2020cites this paper
• Stress, Sex, and Sugar: Glucocorticoids and Sex-Steroid Crosstalk in the Sex-Specific Misprogramming of Metabolism

  2020cites this paper
• Compound A inhibits urothelial tumorigenesis via both the androgen receptor and glucocorticoid receptor signaling pathways.

  2020cites this paper
• Androgen receptor signalling in the male adrenal facilitates X-zone regression, cell turnover and protects against adrenal degeneration during ageing

  2019cites this paper
• Androgens modulate glucocorticoid receptor activity in adipose tissue and liver.

  2019cites this paper
• Roles of the HOXA10 gene during castrate-resistant prostate cancer progression.

  2019cites this paper
• Heme Oxygenase 1 Impairs Glucocorticoid Receptor Activity in Prostate Cancer

  2019cites this paper
• Analyse protéomique des réseaux de signalisation du récepteur aux androgènes modulés par l'Enzalutamide dans le cancer de la prostate résistant à la castration

  2019influential citation
• The Role of Mineralocorticoid Receptor Signaling in Genitourinary Cancers

  2019cites this paper
• Transcriptional repression by androgen receptor: roles in castration-resistant prostate cancer

  2019cites this paper
• Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone.

  2019cites this paper
• RETRACTED ARTICLE: Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling

  2019cites this paper
• HnRNPM is a potential mediator of YY1 which promotes EMT in prostate cancer cells

  2019cites this paper
• Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid Receptor

  2019cites this paper
• Taxane-based Chemotherapy Induced Androgen Receptor Splice Variant 7 in Patients with Castration-Resistant Prostate Cancer: A Tissue-based Analysis

  2019cites this paper
• Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma

  2019cites this paper
• Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer

  2019cites this paper
• Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer

  2019cites this paper
• Does increased expression of glucocorticoid receptor support application of antagonists to this receptor for the treatment of castration resistant prostate cancer?

  2018cites this paper
• Androgen receptor reverts dexamethasone-induced inhibition of prostate cancer cell proliferation and migration

  2018cites this paper
• Delineation of the androgen‐regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches

  2018cites this paper
• Determining the role of androgen receptor and glucocorticoid receptor in the rodent adrenal cortex through conditional gene targeting

  2018influential citation
• α-Viniferin activates autophagic apoptosis and cell death by reducing glucocorticoid receptor expression in castration-resistant prostate cancer cells

  2018cites this paper
• The Role of Glucocorticoid Receptor Signaling in Bladder Cancer Progression

  2018cites this paper
• Loss of Nuclear Functions of HOXA10 Is Associated With Testicular Cancer Proliferation

  2018cites this paper
• Targeting the glucocorticoid receptor for a combinatory treatment strategy for castration resistant prostate cancer

  2018cites this paper
• Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

  2018cites this paper
• The role of glucocorticoid receptor in prostate cancer progression: from bench to bedside

  2017cites this paper
• Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance

  2017cites this paper
• Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression

  2017cites this paper
• Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth

  2017cites this paper
• Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression

  2017cites this paper
• The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy

  2017influential citation
• Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy

  2017cites this paper
• Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives

  2017cites this paper
• Possible roles for glucocorticoid signalling in breast cancer.

  2017cites this paper
• Endostatin inhibits androgen‐independent prostate cancer growth by suppressing nuclear receptor‐mediated oxidative stress

  2017cites this paper
• Role of spliceosome proteins in the regulation of glucocorticoid receptor isoforms by cortisol and dehydroepiandrosterone

  2017cites this paper
• The preclinical development of novel treatment options for advanced prostate cancer

  2016cites this paper
• Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer

  2016cites this paper
• A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer

  2016cites this paper
• Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer

  2016cites this paper
• Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide.

  2016cites this paper
• SMC 1 A promotes growth and migration of prostate cancer in vitro and in vivo

  2016influential citation
• SMC1A promotes growth and migration of prostate cancer in vitro and in vivo.

  2016cites this paper
• Therapy escape mechanisms in the malignant prostate.

  2015cites this paper
• Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer

  2015cites this paper
• Targeting the glucocorticoid receptor in breast and prostate cancers

  2015cites this paper
• Competitive and compensatory effects of androgen signaling and glucocorticoid signaling

  2015cites this paper
• Molecular genetic mechanisms of drug resistance in prostate cancer

  2015influential citation
• HER2 as a novel therapeutic target for cervical cancer

  2015cites this paper
• Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling.

  2015cites this paper
• In vitro and in vivo model systems used in prostate cancer research.

  2015cites this paper
• Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer

  2015cites this paper
• HoxA13 Regulates Phenotype Regionalization of Human Pregnant Myometrium.

  2015cites this paper
• Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression

  2015cites this paper
• Progesterone receptor expression during prostate cancer progression suggests a role of this receptor in stromal cell differentiation

  2015cites this paper
• Driver or Passenger - Roles of the Glucocorticoid Receptor in Castration Resistance Prostate Cancers

  2014cites this paper